These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30688385)

  • 61. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.
    Brun E; Kjellén E; Tennvall J; Ohlsson T; Sandell A; Perfekt R; Perfekt R; Wennerberg J; Strand SE
    Head Neck; 2002 Feb; 24(2):127-35. PubMed ID: 11891942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor volumes measured from static and dynamic 18F-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography scan: comparison of different methods using magnetic resonance imaging as the criterion standard.
    Chen H; Jiang J; Gao J; Liu D; Axelsson J; Cui M; Gong NJ; Feng ST; Luo L; Huang B
    J Comput Assist Tomogr; 2014; 38(2):209-15. PubMed ID: 24625616
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
    Rasmussen JH; Håkansson K; Vogelius IR; Aznar MC; Fischer BM; Friborg J; Loft A; Kristensen CA; Bentzen SM; Specht L
    Radiother Oncol; 2016 Jul; 120(1):76-80. PubMed ID: 26993418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
    Xie P; Li M; Zhao H; Sun X; Fu Z; Yu J
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1085-93. PubMed ID: 21229262
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
    Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
    Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
    Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
    Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
    J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
    Nakasone Y; Inoue T; Oriuchi N; Takeuchi K; Negishi A; Endo K; Mogi K
    Ann Nucl Med; 2001 Dec; 15(6):505-12. PubMed ID: 11831398
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.
    Allal AS; Dulguerov P; Allaoua M; Haenggeli CA; El-Ghazi el A; Lehmann W; Slosman DO
    J Clin Oncol; 2002 Mar; 20(5):1398-404. PubMed ID: 11870185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.
    Seol YM; Kwon BR; Song MK; Choi YJ; Shin HJ; Chung JS; Cho GJ; Lee JC; Lee BJ; Wang SG; Kim HJ; Kim WT; Kim SJ; Yun EY
    Acta Oncol; 2010; 49(2):201-8. PubMed ID: 20100156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.
    Greco C; Nehmeh SA; Schöder H; Gönen M; Raphael B; Stambuk HE; Humm JL; Larson SM; Lee NY
    Am J Clin Oncol; 2008 Oct; 31(5):439-45. PubMed ID: 18838879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
    Demirci U; Coskun U; Akdemir UO; Benekli M; Kapucu O; Ozkan S; Cakir T; Baykara M; Buyukberber S
    Asian Pac J Cancer Prev; 2011; 12(7):1817-20. PubMed ID: 22126572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.
    Burri RJ; Rangaswamy B; Kostakoglu L; Hoch B; Genden EM; Som PM; Kao J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):682-8. PubMed ID: 18258379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.
    Allal AS; Slosman DO; Kebdani T; Allaoua M; Lehmann W; Dulguerov P
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1295-300. PubMed ID: 15275712
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
    Zhang B; Geng J; Nie F; Li X
    Oncol Res Treat; 2015; 38(1-2):45-8. PubMed ID: 25633888
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
    Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
    AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.